Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 9726503, 10 pages
http://dx.doi.org/10.1155/2016/9726503
Research Article

Heme Oxygenase-1 Promotes Delayed Wound Healing in Diabetic Rats

1Medical Department, General Hospital of Jinan Military Command, 25 Shifan Road, Jinan, Shandong 250031, China
2Department of Pathophysiology, Wannan Medical College, Wuhu 241002, China
3Department of Physiology, Wannan Medical College, Wuhu 241002, China

Received 5 June 2015; Revised 7 September 2015; Accepted 13 September 2015

Academic Editor: Paolo Fiorina

Copyright © 2016 Qing-Ying Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Huang, A. Basu, M. O'Grady, and J. C. Capretta, “Projecting the future diabetes population size and related costs for the U.S.,” Diabetes Care, vol. 32, no. 12, pp. 2225–2229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Johannesson, G.-U. Larsson, N. Ramstrand, A. Turkiewicz, A.-B. Wiréhn, and I. Atroshi, “Incidence of lower-limb amputation in the diabetic and nondiabetic general population: a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations,” Diabetes Care, vol. 32, no. 2, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Faglia, G. Clerici, J. Clerissi et al., “Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study,” Diabetes Care, vol. 32, no. 5, pp. 822–827, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Falanga, “Wound healing and its impairment in the diabetic foot,” The Lancet, vol. 366, no. 9498, pp. 1736–1743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. I. F. Moura, A. M. A. Dias, E. Carvalho, and H. C. de Sousa, “Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review,” Acta Biomaterialia, vol. 9, no. 7, pp. 7093–7114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. Reaven, “Pathophysiology of insulin resistance in human disease,” Physiological Reviews, vol. 75, no. 3, pp. 473–486, 1995. View at Google Scholar · View at Scopus
  7. M. S. Zguira, S. Vincent, S. Le Douairon Lahaye, L. Malarde, Z. Tabka, and B. Saïag, “Intense exercise training is not effective to restore the endothelial NO-dependent relaxation in STZ-diabetic rat aorta,” Cardiovascular Diabetology, vol. 12, article 32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Andersen and T. S. Roukis, “The diabetic foot,” Surgical Clinics of North America, vol. 87, no. 5, pp. 1149–1177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Jeffcoate and K. G. Harding, “Diabetic foot ulcers,” The Lancet, vol. 361, no. 9368, pp. 1545–1551, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Lobmann, A. Ambrosch, G. Schultz, K. Waldmann, S. Schiweck, and H. Lehnert, “Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients,” Diabetologia, vol. 45, no. 7, pp. 1011–1016, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. H. Bach, “Heme oxygenase-1 and transplantation tolerance,” Human Immunology, vol. 67, no. 6, pp. 430–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Öllinger, H. Wang, K. Yamashita et al., “Therapeutic applications of bilirubin and biliverdin in transplantation,” Antioxidants & Redox Signaling, vol. 9, no. 12, pp. 2175–2185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. E. Otterbein, M. P. Soares, K. Yamashita, and F. H. Bach, “Heme oxygenase-1: unleashing the protective properties of heme,” Trends in Immunology, vol. 24, no. 8, pp. 449–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Soares and F. H. Bach, “Heme oxygenase-1 in organ transplantation,” Frontiers in Bioscience, vol. 12, no. 1, pp. 4932–4945, 2007. View at Google Scholar
  15. M.-L. Wu, Y.-C. Ho, and S.-F. Yet, “A central role of heme oxygenase-1 in cardiovascular protection,” Antioxidants & Redox Signaling, vol. 15, no. 7, pp. 1835–1846, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Loboda, A. Jazwa, A. Grochot-Przeczek et al., “Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities,” Antioxidants & Redox Signaling, vol. 10, no. 10, pp. 1767–1812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Dulak, J. Deshane, A. Jozkowicz, and A. Agarwal, “Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis,” Circulation, vol. 117, no. 2, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Józkowicz and J. Dulak, “Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages,” Acta Biochimica Polonica, vol. 50, no. 1, pp. 69–79, 2003. View at Google Scholar · View at Scopus
  19. T. Jansen, M. Hortmann, M. Oelze et al., “Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin,” Journal of Molecular and Cellular Cardiology, vol. 49, no. 2, pp. 186–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. W. Ryter and A. M. K. Choi, “Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 3, pp. 251–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. P. Vacek, W. Gillespie, N. Tyagi, J. C. Vacek, and S. C. Tyagi, “Hydrogen sulfide protects against vascular remodeling from endothelial damage,” Amino Acids, vol. 39, no. 5, pp. 1161–1169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Calvert, S. Jha, S. Gundewar et al., “Hydrogen sulfide mediates cardioprotection through nrf2 signaling,” Circulation Research, vol. 105, no. 4, pp. 365–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. C. O. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J. L. Wallace, “Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation,” The FASEB Journal, vol. 20, no. 12, pp. 2118–2120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. G. Wang, W. Li, Q. Y. Chen, Y. X. Jiang, X. H. Lu, and X. Zhao, “Hydrogen sulfide accelerates wound healing in diabetic rats,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 5097–5104, 2015. View at Google Scholar
  25. R. Blakytny and E. Jude, “The molecular biology of chronic wounds and delayed healing in diabetes,” Diabetic Medicine, vol. 23, no. 6, pp. 594–608, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Fiorina, G. Pietramaggiori, S. S. Scherer et al., “The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing,” Cell Transplantation, vol. 19, no. 11, pp. 1369–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. S. Scherer, G. Pietramaggiori, J. C. Mathews, R. Chan, P. Fiorina, and D. P. Orgill, “Wound healing kinetics of the genetically diabetic mouse,” Wounds, vol. 20, no. 1, pp. 18–28, 2008. View at Google Scholar · View at Scopus
  28. D. J. Grieve, J. A. Byrne, A. C. Cave, and A. M. Shah, “Role of oxidative stress in cardiac remodelling after myocardial infarction,” Heart Lung and Circulation, vol. 13, no. 2, pp. 132–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Molavi and J. L. Mehta, “Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations,” Current Opinion in Cardiology, vol. 19, no. 5, pp. 488–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. G.-G. Wang, W. Li, X.-H. Lu, X. Zhao, and L. Xu, “Taurine attenuates oxidative stress and alleviates cardiac failure in type 1 diabetic rats,” Croatian Medical Journal, vol. 54, no. 2, pp. 171–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Bassi, A. Vergani, F. D'Addio et al., “Positive effects of a novel non-peptidyl low molecular weight radical scavenger in renal ischemia/reperfusion: a preliminary report,” SpringerPlus, vol. 3, article 158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. K. C. Manthey, Y. C. Chew, and J. Zempleni, “Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress response systems,” Journal of Nutrition, vol. 135, no. 5, pp. 978–982, 2005. View at Google Scholar · View at Scopus
  33. J. Doupis, T. E. Lyons, S. Wu, C. Gnardellis, T. Dinh, and A. Veves, “Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy,” Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 6, pp. 2157–2163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. Haidara, D. P. Mikhailidis, M. A. Rateb et al., “Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes,” Journal of Diabetes and Its Complications, vol. 23, no. 2, pp. 130–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill, “Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1728–H1736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Ho, G. Chen, and T. M. Bray, “Supplementation of N-acetylcysteine inhibits NFκB activation and protects against alloxan-induced diabetes in CD-1 mice,” The FASEB Journal, vol. 13, no. 13, pp. 1845–1854, 1999. View at Google Scholar · View at Scopus
  37. A. M. Rasik and A. Shukla, “Antioxidant status in delayed healing type of wounds,” International Journal of Experimental Pathology, vol. 81, no. 4, pp. 257–263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. N.-Y. Park and Y. Lim, “Short term supplementation of dietary antioxidants selectively regulates the inflammatory responses during early cutaneous wound healing in diabetic mice,” Nutrition and Metabolism, vol. 8, article 80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Tanabe and V. Ullrich, “Prostacyclin and thromboxane synthases,” Journal of Lipid Mediators and Cell Signalling, vol. 12, no. 2-3, pp. 243–255, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. E. M. Smyth, “Thromboxane and the thromboxane receptor in cardiovascular disease,” Clinical Lipidology, vol. 5, no. 2, pp. 209–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. D. Katugampola and A. P. Davenport, “Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1 receptor antagonist losartan,” British Journal of Pharmacology, vol. 134, no. 7, pp. 1385–1392, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Fuse and T. Kamiya, “Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease,” Circulation, vol. 90, no. 6, pp. 2952–2955, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Kobayashi, Y. Tahara, M. Matsumoto et al., “Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice,” The Journal of Clinical Investigation, vol. 114, no. 6, pp. 784–794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Gresele, H. Deckmyn, G. G. Nenci, and J. Vermylen, “Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders,” Trends in Pharmacological Sciences, vol. 12, pp. 158–163, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Sakai, T. Suzuki, M. Murota et al., “E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon,” British Journal of Pharmacology, vol. 136, no. 3, pp. 383–390, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. B. D. Guth, H. Narjes, H.-D. Schubert, P. Tanswell, A. Riedel, and G. Nehmiz, “Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects,” British Journal of Clinical Pharmacology, vol. 58, no. 1, pp. 40–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Wang, Z.-H. Xie, Y.-J. Guo et al., “VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease,” Biochemical and Biophysical Research Communications, vol. 411, no. 3, pp. 620–626, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Hou, L. Shen, Q. Huang et al., “The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer,” Biomaterials, vol. 34, no. 1, pp. 112–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Roskoski Jr., “VEGF receptor protein-tyrosine kinases: structure and regulation,” Biochemical and Biophysical Research Communications, vol. 375, no. 3, pp. 287–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. A. K. Hubbard and R. Rothlein, “Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades,” Free Radical Biology and Medicine, vol. 28, no. 9, pp. 1379–1386, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. T. A. Springer, “Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm,” Cell, vol. 76, no. 2, pp. 301–314, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Kimura and H. Kimura, “Hydrogen sulfide protects neurons from oxidative stress,” The FASEB Journal, vol. 18, no. 10, pp. 1165–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. N. L. Whitfield, E. L. Kreimier, F. C. Verdial, N. Skovgaard, and K. R. Olson, “Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 294, no. 6, pp. R1930–R1937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Wang, “The gasotransmitter role of hydrogen sulfide,” Antioxidants and Redox Signaling, vol. 5, no. 4, pp. 493–501, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Li, M. Whiteman, Y. Y. Guan et al., “Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide,” Circulation, vol. 117, no. 18, pp. 2351–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Szabó, “Hydrogen sulphide and its therapeutic potential,” Nature Reviews Drug Discovery, vol. 6, no. 11, pp. 917–935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M.-J. Wang, W.-J. Cai, N. Li, Y.-J. Ding, Y. Chen, and Y.-C. Zhu, “The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia,” Antioxidants & Redox Signaling, vol. 12, no. 9, pp. 1065–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Coletta, A. Papapetropoulos, K. Erdelyi et al., “Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 9161–9166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. H. J. Lee, M. M. Mariappan, D. Feliers et al., “Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells,” The Journal of Biological Chemistry, vol. 287, no. 7, pp. 4451–4461, 2012. View at Publisher · View at Google Scholar · View at Scopus